Jun 14, 2023 / 06:20PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
All right. It's great. Thanks, everyone, for joining us. I'm Matt Sykes for the Life Science Tools and Diagnostics Analyst at Goldman Sachs. I have the pleasure of having the senior management team from NeoGenomics here today. Chris Smith, the CEO; Jeff Sherman, the CFO; and Warren Stone, President of Clinical Services.
Chris, Jeff, Warren, thank you very much for joining us.
Christopher Michael Smith - NeoGenomics, Inc. - CEO & Director
Yes. Good to be here.
Jeffrey S. Sherman - NeoGenomics, Inc. - CFO
Thank you.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystMaybe if we'll start out, Chris, and you guys can chime in as well, just sort of set the stage in terms of talking about first quarter results and some of the trends you're seeing in the business and what your expectations are for the second half